Allergan Aesthetics, an AbbVie (NYSE: ABBV) company, today announced Allergan Medical Institute (AMI) will open three new ...

Allergan is still on the acquisition trail following its failed merger with Pfizer, spending $85 million to acquire privately-held Topokine Therapeutics and its late-stage product for under-eye bags.

The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...

Allergan will acquire California-based Bonti for an upfront payment of $195 million and additional potential commercial milestone payments, subject to certain adjustments and other customary ...

AbbVie launched a revamped version of its Allē loyalty program, which ultimately was not adopted by providers. The marketing ...

Merger deal, which values Allergan at around $160 billion, allows Pfizer to locate its tax base in Ireland ...

ALLERGAN Chief Executive, Brent Saunders, has confirmed the company plans to significantly expand its Irish operations with ...

NORTH CHICAGO, Ill., Jan. 29, 2025 /PRNewswire/ -- In response to growing demand for personalized, patient-centric aesthetic solutions1,2, Allergan Aesthetics, an AbbVie Company, is proud to ...

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced a nationwide open casting call in search of the next Faces of Natrelle®, encouraging women who have experienced breast reconstruction and ...

Talk to your doctor about other complications. At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics ...